These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10381493)

  • 1. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.
    Lo Coco F; Diverio D; Falini B; Biondi A; Nervi C; Pelicci PG
    Blood; 1999 Jul; 94(1):12-22. PubMed ID: 10381493
    [No Abstract]   [Full Text] [Related]  

  • 2. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
    Kitamura K; Takeshita A; Ono R; Naoe T
    Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of APL and the molecular basis of retinoic acid treatment.
    Casini T; Grignani F; Pelicci PG
    Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17).
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Willman CL
    Leukemia; 2000 Jul; 14(7):1197-200. PubMed ID: 10914542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
    Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Reyes-Núñez V
    Acta Haematol; 2000; 104(2-3):124-7. PubMed ID: 11154988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
    Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
    Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
    [No Abstract]   [Full Text] [Related]  

  • 7. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
    Rashidi A; Fisher SI
    Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
    Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
    Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL).
    Grimwade D; Langabeer S; Howe K; Solomon E
    Methods Mol Biol; 1998; 89():333-58. PubMed ID: 9664338
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular follow-up of patients with promyelocytic leukaemia treated with all-trans retinoic acid.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
    Clin Lab Haematol; 1998 Jun; 20(3):173-6. PubMed ID: 9681233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R
    Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia.
    Nicci C; Ottaviani E; Luatti S; Grafone T; Tonelli M; Motta MR; Malagola M; Marzocchi G; Martinelli G; Baccarani M; Testoni N
    Leukemia; 2005 Mar; 19(3):470-2. PubMed ID: 15674421
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
    Iqbal S; Grimwade D; Chase A; Goldstone A; Burnett A; Goldman JM; Swirsky D
    Leukemia; 2000 May; 14(5):950-3. PubMed ID: 10803535
    [No Abstract]   [Full Text] [Related]  

  • 14. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
    Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
    Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
    [No Abstract]   [Full Text] [Related]  

  • 15. APL, a model disease for cancer therapies?
    de Thé H; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
    [No Abstract]   [Full Text] [Related]  

  • 16. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia.
    Côté S; Zhou D; Bianchini A; Nervi C; Gallagher RE; Miller WH
    Blood; 2000 Nov; 96(9):3200-8. PubMed ID: 11050004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F; Diverio D; Avvisati G; Mandelli F
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute promyelocytic leukemia--weapons of mass differentiation.
    Licht JD
    N Engl J Med; 2009 Feb; 360(9):928-30. PubMed ID: 19246367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis of acute promyelocytic leukemia].
    Tokuhira M; Kizaki M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():409-14. PubMed ID: 23133991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.